GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alar Pharmaceuticals Inc (ROCO:6785) » Definitions » Common Stock

Alar Pharmaceuticals (ROCO:6785) Common Stock : NT$668.00 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Alar Pharmaceuticals Common Stock?

Alar Pharmaceuticals's quarterly common stock stayed the same from Jun. 2024 (NT$668.00 Mil) to Sep. 2024 (NT$668.00 Mil) and stayed the same from Sep. 2024 (NT$668.00 Mil) to Dec. 2024 (NT$668.00 Mil).

Alar Pharmaceuticals's annual common stock stayed the same from Dec. 2022 (NT$570.00 Mil) to Dec. 2023 (NT$570.00 Mil) but then increased from Dec. 2023 (NT$570.00 Mil) to Dec. 2024 (NT$668.00 Mil).


Alar Pharmaceuticals Common Stock Historical Data

The historical data trend for Alar Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alar Pharmaceuticals Common Stock Chart

Alar Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial 570.00 570.00 570.00 570.00 668.00

Alar Pharmaceuticals Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 570.00 668.00 668.00 668.00 668.00

Alar Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Alar Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 32, Keya Road, 5th Floor, Daya District, Taichung, TWN, 407
Alar Pharmaceuticals Inc is a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and depressive disorder. These chronic diseases not only cause long-term burdens to the patients and their families but also consume huge social costs.

Alar Pharmaceuticals Headlines

No Headlines